Last year, Victoza made 982m of sales, down by 30% on 2022, while Saxenda posted revenues of 1.2bn, down 4%
This content has been reviewed and approved by our team of medical providers
HAVGLO INJECTION is used to manage alcoholic fatty liver (disease that occurs due to heavy alcohol use), liver fibrosis/cirrhosis (scarring of liver due to excessive consumption of alcohol), and hepatitis (inflammation of liver) in affected individuals
We offer evidence-based solutions, including targeted probiotics, herbal antimicrobials, and motility support, to address the root cause of your symptoms and reduce recurrence rates
Your clinician can help you determine which method best suits your needs